BR112022015461A2 - Polipeptídeos, ácido nucleico, vetor, célula hospedeira, proteínas de base do penton de adenovírus, complexo pentamérico, partícula semelhante a vírus (vlp), composição farmacêutica, métodos para produzir a vlp e para a produção de um polipeptídeo e método de identificação de uma sequência de ligação - Google Patents
Polipeptídeos, ácido nucleico, vetor, célula hospedeira, proteínas de base do penton de adenovírus, complexo pentamérico, partícula semelhante a vírus (vlp), composição farmacêutica, métodos para produzir a vlp e para a produção de um polipeptídeo e método de identificação de uma sequência de ligaçãoInfo
- Publication number
- BR112022015461A2 BR112022015461A2 BR112022015461A BR112022015461A BR112022015461A2 BR 112022015461 A2 BR112022015461 A2 BR 112022015461A2 BR 112022015461 A BR112022015461 A BR 112022015461A BR 112022015461 A BR112022015461 A BR 112022015461A BR 112022015461 A2 BR112022015461 A2 BR 112022015461A2
- Authority
- BR
- Brazil
- Prior art keywords
- vlp
- polypeptide
- adenovirus
- polypeptides
- virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10323—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10333—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20155742 | 2020-02-05 | ||
| EP20155982 | 2020-02-06 | ||
| PCT/EP2021/052884 WO2021156489A1 (en) | 2020-02-05 | 2021-02-05 | Engineered polypeptides derived from variable domain of adenovirus penton base |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022015461A2 true BR112022015461A2 (pt) | 2022-10-11 |
Family
ID=74561908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022015461A BR112022015461A2 (pt) | 2020-02-05 | 2021-02-05 | Polipeptídeos, ácido nucleico, vetor, célula hospedeira, proteínas de base do penton de adenovírus, complexo pentamérico, partícula semelhante a vírus (vlp), composição farmacêutica, métodos para produzir a vlp e para a produção de um polipeptídeo e método de identificação de uma sequência de ligação |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230101439A1 (https=) |
| EP (1) | EP4100421A1 (https=) |
| JP (1) | JP2023513512A (https=) |
| CN (1) | CN115427431A (https=) |
| AU (1) | AU2021216124A1 (https=) |
| BR (1) | BR112022015461A2 (https=) |
| CA (1) | CA3166852A1 (https=) |
| MX (1) | MX2022009574A (https=) |
| WO (1) | WO2021156489A1 (https=) |
| ZA (1) | ZA202209759B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024042100A1 (en) | 2022-08-22 | 2024-02-29 | Imophoron Limited | Adenovirus penton-based virus-like particles |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4597188B2 (ja) | 2004-03-09 | 2010-12-15 | アイトゲネシシェ・テヒニーシェ・ホッホシューレ・チューリッヒ | 多タンパク質適用のための新規発現ツール |
| JP2012519476A (ja) | 2009-03-06 | 2012-08-30 | ヨーロピアン モレキュラー バイオロジー ラボラトリー | 多タンパク質複合体のクローニング及び発現のための核酸 |
| PL222497B1 (pl) * | 2009-06-26 | 2016-08-31 | Inst Biochemii I Biofizyki Pan | Wektorowa cząsteczka wirusopodobna, sposób jej wytwarzania, kompozycja farmaceutyczna oraz zastosowanie wektorowej cząsteczki wirusopodobnej |
| EP3436591B1 (en) | 2016-03-31 | 2023-01-04 | The European Molecular Biology Laboratory | Adenoviral coat protein derived delivery vehicles |
| WO2019016756A1 (en) * | 2017-07-21 | 2019-01-24 | Glaxosmithkline Biologicals Sa | ANTIGEN CONSTRUCTS OF CHIKUNGUNYA VIRUSES |
| SG11202100898UA (en) * | 2018-07-31 | 2021-02-25 | Imophoron Ltd | Multimerizing polypeptides derived from jelly roll fold domain of adenovirus penton base |
-
2021
- 2021-02-05 MX MX2022009574A patent/MX2022009574A/es unknown
- 2021-02-05 BR BR112022015461A patent/BR112022015461A2/pt not_active IP Right Cessation
- 2021-02-05 WO PCT/EP2021/052884 patent/WO2021156489A1/en not_active Ceased
- 2021-02-05 CA CA3166852A patent/CA3166852A1/en active Pending
- 2021-02-05 AU AU2021216124A patent/AU2021216124A1/en not_active Abandoned
- 2021-02-05 JP JP2022547688A patent/JP2023513512A/ja active Pending
- 2021-02-05 CN CN202180024156.1A patent/CN115427431A/zh active Pending
- 2021-02-05 US US17/797,941 patent/US20230101439A1/en active Pending
- 2021-02-05 EP EP21703917.1A patent/EP4100421A1/en not_active Withdrawn
-
2022
- 2022-08-31 ZA ZA2022/09759A patent/ZA202209759B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230101439A1 (en) | 2023-03-30 |
| WO2021156489A1 (en) | 2021-08-12 |
| CN115427431A (zh) | 2022-12-02 |
| ZA202209759B (en) | 2023-07-26 |
| EP4100421A1 (en) | 2022-12-14 |
| AU2021216124A1 (en) | 2022-09-29 |
| MX2022009574A (es) | 2022-11-16 |
| CA3166852A1 (en) | 2021-08-12 |
| JP2023513512A (ja) | 2023-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Llorca et al. | Eukaryotic chaperonin CCT stabilizes actin and tubulin folding intermediates in open quasi‐native conformations | |
| Boudko et al. | The crucial role of trimerization domains in collagen folding | |
| Bond et al. | Coarse-grained molecular dynamics simulations of the energetics of helix insertion into a lipid bilayer | |
| Franzot et al. | The crystal structure of the actin binding domain from α-actinin in its closed conformation: structural insight into phospholipid regulation of α-actinin | |
| Kunji et al. | The mitochondrial ADP/ATP carrier exists and functions as a monomer | |
| Luo et al. | Self‐organization of a chiral D‐EAK16 designer peptide into a 3D nanofiber scaffold | |
| US8969521B2 (en) | General method for designing self-assembling protein nanomaterials | |
| Abu-Baker et al. | Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study | |
| BR112022015461A2 (pt) | Polipeptídeos, ácido nucleico, vetor, célula hospedeira, proteínas de base do penton de adenovírus, complexo pentamérico, partícula semelhante a vírus (vlp), composição farmacêutica, métodos para produzir a vlp e para a produção de um polipeptídeo e método de identificação de uma sequência de ligação | |
| Dinjaski et al. | Integrated modeling and experimental approaches to control silica modification of design silk-based biomaterials | |
| Pinotsis et al. | Evidence for a dimeric assembly of two titin/telethonin complexes induced by the telethonin C-terminus | |
| Verdone et al. | The solution structure of EMILIN1 globular C1q domain reveals a disordered insertion necessary for interaction with the α4β1 integrin | |
| Reißer et al. | Best of two worlds? How MD simulations of amphiphilic helical peptides in membranes can complement data from oriented solid-state NMR | |
| Kjaergaard et al. | Solution structure of recombinant somatomedin B domain from vitronectin produced in Pichia pastoris | |
| Kairys et al. | Structural model for an AxxxG‐mediated dimer of surfactant‐associated protein C | |
| Calero-Rubio et al. | Predicting unfolding thermodynamics and stable intermediates for alanine-rich helical peptides with the aid of coarse-grained molecular simulation | |
| Campos et al. | Modeling pilus structures from sparse data | |
| Nowitzke et al. | Mechanical unfolding of network nodes drives the stress response of protein-based materials | |
| Khew et al. | Template-assembled triple-helical peptide molecules: mimicry of collagen by molecular architecture and integrin-specific cell adhesion | |
| Qu et al. | Engineered design of the E-helix structure on ferritin nanoparticles | |
| Sokolova | Structure of cation channels, revealed by single particle electron microscopy | |
| Poluri et al. | World of proteins: Structure-function relationships and engineering techniques | |
| Haspel et al. | A protocol for the design of protein and peptide nanostructure self-assemblies exploiting synthetic amino acids | |
| Arkin et al. | How conformational transition depends on hydrophobicity of elastin-like polypeptides | |
| Hartgerink | Advancing Collagen Mimicry: Covalent Triple Helix Stabilization and Higher-order Nanostructure Design |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2865 DE 02-12-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |